Evaluation Of Sperm Production With Healthy Male Volunteers Receiving Lyrica Or Placebo
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This study is being performed as a Phase IV FDA commitment study and is being powered
adequately to assess changes in sperm concentration, FSH and testosterone in healthy male
subjects treated with pregabalin as compared to placebo, in addition to confirming lack of
effects on sperm motility.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.